Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter Gale

Showing results (121-130 of 557) with videos related to

Pageof 56
Sort By:
JAMA Oncology|October 30, 2025
Rethinking End Points in Modern Oncology Trials-Beyond the P ValueQiujin Shen, Robert Peter Gale, Junren Chen
Journal of Hematology & Oncology|December 16, 2014
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemiaBing Li, Robert Peter Gale, Zhijian Xiao
Blood Advances|November 13, 2023
JAK2V617F and ischemic stroke: CHIP or CMD-NBV?Giovanni Barosi, Vittorio Rosti, Robert Peter Gale
Leukemia|March 4, 2023
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectivesGiovanni Barosi, Vittorio Rosti, Robert Peter Gale
Leukemia|November 10, 2023
What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia?Tomas Radivoyevitch, Robert Peter Gale, Matt E Kalaycio
JAMA Oncology|July 31, 2020
Microtransplantation for Acute Myeloid Leukemia: A Systematic ReviewBin Pan, Hillard M Lazarus, Robert Peter Gale
Stem Cells (Dayton, Ohio)|August 14, 2013
Concise review: bone marrow autotransplants for liver disease?Iman Saramipoor Behbahan, Armand Keating, Robert Peter Gale
Leukemia|July 29, 2023
Why are haematopoietic stem cells in the bone marrow: ontology recapitulates phylogenyRobert Peter Gale, James Welsh, P Andrew Karam
Expert Review of Hematology|March 15, 2023
Hematopoietic cell transplants in resource-poor countries: challenges and opportunitiesGregorio Jaimovich, Hillard M Lazarus, Robert Peter Gale
Journal of Cancer Research and Clinical Oncology|April 22, 2021
Economics influences therapy decisions in chronic myeloid leukaemia: should it?Qian Jiang, Richard A Larson, Robert Peter Gale
Pageof 56

Showing results (121-130 of 557) with videos related to

Sort By:
Pageof 56
JAMA Oncology|October 30, 2025
Rethinking End Points in Modern Oncology Trials-Beyond the P ValueQiujin Shen, Robert Peter Gale, Junren Chen
Journal of Hematology & Oncology|December 16, 2014
Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemiaBing Li, Robert Peter Gale, Zhijian Xiao
Blood Advances|November 13, 2023
JAK2V617F and ischemic stroke: CHIP or CMD-NBV?Giovanni Barosi, Vittorio Rosti, Robert Peter Gale
Leukemia|March 4, 2023
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectivesGiovanni Barosi, Vittorio Rosti, Robert Peter Gale
Leukemia|November 10, 2023
What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia?Tomas Radivoyevitch, Robert Peter Gale, Matt E Kalaycio
JAMA Oncology|July 31, 2020
Microtransplantation for Acute Myeloid Leukemia: A Systematic ReviewBin Pan, Hillard M Lazarus, Robert Peter Gale
Stem Cells (Dayton, Ohio)|August 14, 2013
Concise review: bone marrow autotransplants for liver disease?Iman Saramipoor Behbahan, Armand Keating, Robert Peter Gale
Leukemia|July 29, 2023
Why are haematopoietic stem cells in the bone marrow: ontology recapitulates phylogenyRobert Peter Gale, James Welsh, P Andrew Karam
Expert Review of Hematology|March 15, 2023
Hematopoietic cell transplants in resource-poor countries: challenges and opportunitiesGregorio Jaimovich, Hillard M Lazarus, Robert Peter Gale
Journal of Cancer Research and Clinical Oncology|April 22, 2021
Economics influences therapy decisions in chronic myeloid leukaemia: should it?Qian Jiang, Richard A Larson, Robert Peter Gale
Pageof 56